Drug-Delivering Nanoyarn Could Promote Effective Reconstruction of Functional Urethra in Dog by Inhibiting Wnt/Β-Catenin Signaling

Kaile Zhang,Xiaolan Fang,Jingjing Zhu,Ranxing Yang,Ying Wang,Weixin Zhao,Xiumei Mo,Qiang Fu

DOI: https://doi.org/10.2139/ssrn.3454941

2019-01-01

Abstract:Hypospadias and urethral stricture are common urological diseases which seriously affect voiding function and life quality of the patients. Current clinical treatments using autologous tissues or tissue engineered grafts often result in unsatisfactory clinical outcome with frequent complications at tissue-harvesting organ(s). In the present study, we performed RNA profiling (mRNA and miRNA sequencing) using urethral stricture animal model. Functional enrichment analysis of differential expressed genes showed that CTNNB1-centered Wnt signaling were significantly regulated during the scar formation and fibrosis, suggesting Wnt pathway as a promising therapeutic target for clinical treatment of urethral defects. In vitro experiments confirmed that ICG-001 (a well-established Wnt signaling inhibitor) could effectively prohibit fibroblast proliferation and the expression of fibrosis associated proteins. To testify whether inhibition of Wnt signaling could benefit tissue reconstruction from urethral defects in vivo, we applied a novel drug-delivering nanoyarn scaffold in urethroplasty in dog model, which could continuously deliver ICG-001 during the tissue reconstruction. The ICG-001 delivering nanoyarn could effectively promote urethral recovery and resume fully functional urethra within 12 weeks. Such attempts could be essential in the Next Generation Sequencing (NGS)-guided regenerative medicine to cure urethral defects and might be helpful for broader clinical applications in precision medicine.